Combined Therapeutic Approach: Inhibition of MMP-9 and JAK Signaling Synergistically Prevents Depigmentation in Experimental Vitiligo

    Claire Drullion, C Avril, R. Merhi, Julien Sénéschal, K. Boniface
    Studysummary Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →